Argo Biopharma logo

Argo Biopharma

Committed to developing a new generation of siRNA drugs to provide better treatments for global patients.

8 employees · est. 2021 · Shanghai, China

VS
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

Changing the future of Oncology

208 employees · est. 2003 · South San Francisco, United...

Sutro Biopharma, Inc. is the older company (2021 vs 2003); Sutro Biopharma, Inc. is the larger of the two.

Side-by-Side Comparison

Argo Biopharma Sutro Biopharma, Inc.
Founded
2021 2003 older
Headquarters
Shanghai, China South San Francisco, United States
Employees
8 208 larger
Industry
Biotechnology Biotechnology, Information Technology
Funding Stage
Series A IPO
Total Funding
$700.00M $745.90M
Funding Rounds
2 12
Services
Not tracked yet Development of single- and dual-payload ADCs, Oncology research and therapeutics, Scientific and clinical advisory services
Target Customers
Not tracked yet Cancer patients, Healthcare providers, Biopharmaceutical investors, Scientific community
Taxonomy
Not tracked yet Oncology Therapeutics, Cancer Treatment, Antibody Drug Conjugates, Exatecan, Protein Engineering, Biopharmaceutical Development, XpressCF Technology, Cell-free Protein Synthesis, Clinical Stage Drug Development, Multiple Myeloma, Non-Hodgkin Lymphoma, Ovarian Cancer, Endometrial Cancer, Biotechnology Partnerships, Therapeutic Innovation
Website
argobiopharma.com sutrobio.com
Argo Biopharma logo

About Argo Biopharma

Argo Biopharma is a clinical stage biotech company that committed to developing a new generation of siRNA drugs to provide better treatments for global patients. In the past three years, Argo biopharma has built a rich and differentiated pipeline of siRNA drug candidates for a wide range of indicati...

Sutro Biopharma, Inc. logo

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a pioneering player in the oncology sector, driven by its commitment to transform cancer treatment. The company, with the slogan "Changing the future of Oncology," leverages its proprietary XpressCF® technology to develop precisely designed cancer therapeutics, aiming to gre...

We will tell you when either one moves

BounceWatch watches Argo Biopharma and Sutro Biopharma, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Argo Biopharma and Sutro Biopharma, Inc. — by email.

Frequently Asked Questions

Argo Biopharma — Committed to developing a new generation of siRNA drugs to provide better treatments for global patients.. Sutro Biopharma, Inc. — Changing the future of Oncology. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Argo Biopharma has raised $700.00M while Sutro Biopharma, Inc. has raised $745.90M.
Argo Biopharma and Sutro Biopharma, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Argo Biopharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Argo Biopharma on 12 Sep 2024, and Sutro Biopharma, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes